Roche | Momentum Stock Options Trading Alerts and Option Picks Blog

Blogs Directory

EatonWeb Blog Directory

Finance Seek Directory

Dendreon Making Noise Again

Monday, October 12th, 2009

12:40pm (EST)

The market is moving higher today as the Dow now stands 100 points away from 10,000. Currently, the index is up 37 to 9,901 and traded as high as 9,931 earlier this morning. Trading has been fairly light due to the Columbus Day holiday and the bond markets are closed. There are no major economic reports today so the bulls could make their run in the afternoon.

Exxon Mobil (XOM, $70.25, up $0.98) has busted through $70 and I had mentioned that we missed a trade when the stock traded to a low of $66 last Monday. I listed the November 70 calls (XOMKN, $1.85, up $0.35) outside of the Members Area because they were up 40% that day and I didn’t like the entry price of $1.50.

Since it was sort of a “Free Trade”, I thought I would expand my thoughts on the subject. There is resistance at $71-$72 for the stock and if you got in at $1.50, set stops there. If Exxon can muster up some momentum then shares have a shot at $73-$74 where further resistance comes into play. If the stock is at $73 by November 20th, the November 70′s are worth at least $3; at $74 they are worth $4…

One of our favorite Biotech’s is getting a pop today. It looks like Dendreon (DNDN, $29.38, up $1.90) could be on the move again. On the last day of August, we profiled a Dendreon trade that returned subscribers 100% in a little over two weeks. In March, Dendreon made the move from $5 to $25 and some subscribers made 10x that.

Dendreon will submit its application for Provenge to the FDA in November but today’s jump comes on news that the company added two new directors to its board.

One of them is chief executive of Roche’s Genentech unit and the other is a former Eli Lilly (LLY, $33.88, up $0.10) manufacturing executive. I don’t think we get in today but I’m looking at the option chain to see which ones could benefit the most if a buyout offer is coming…

Speaking of noise, Abercrombie & Fitch (ANF, $35.97, up $1.15) has continued its rebound and is setting up nice for us.

I will be back in the morning with the trade updates and possibly some new gems. Let’s hope the bulls continue to push.

Tags: Abercrombie & Fitch, Dendreon, Eli Lilly, Exxon Mobil, momentum trading, options blog, options mentoring, options track record, Roche
Posted in Company Commentary, Earnings, Hot Stocks, Market Analysis, Mergers and Acquisitions, Oil, Option Trades, Sectors, Strategies | Comments Off

Roche Goes Hostile

Friday, January 30th, 2009

Roche threw us a curveball this morning and took its bid for Genentech (DNA, $80.95, down $3.14) directly to the shareholders. The company is now offering about $42 billion, or $86.50 a share for Genentech which is $2.50 less than the offer it made last July. Hogwash.

Roche’s attempt to get Genentech at a lower bid is another slap in the face to its shareholders and although Genentech has not made any comments, this camp says Genentech again holds out for more. One top 10 Genentech shareholder is already rebuffing Roche’s new bid and I don’t believe other shareholders will tender the offer either.

From the head brass at Roche: “We are disappointed that the discussions over the last six months between Roche and the special committee of Genentech have not produced a negotiated agreement. We feel it is now time to give the Genentech minority shareholders the opportunity to decide on our offer. Especially in the current market environment the offer provides an opportunity for all public shareholders to achieve liquidity and to receive a fair price for all their shares.”

Fair price? Geez. If Roche offered $89 back in July, why then, the lower offer? Genentech expects to report results in mid-April for its Avastin colon cancer trial, in addition to pending FDA decisions to expand the drug’s use. Roche is trying to get the rest of the company it does not own before that data is released.

We will have to see how this plays out but continue to hold the the February 95 calls (DWNBS, $0.05, down $0.15) and the March 95 calls (DWNCS, $0.25, down $0.35). These positions got hammered today as a result of the lower bid.

I’ll be back over the weekend to provide an update in the Weekly Wrap.

Rick Rouse
Rick@OptionsMentoring.com

Tags: Genentech, Roche
Posted in Option Trades | No Comments »

Before the Bell – Action in Genentech

Monday, January 12th, 2009

Genentech (DNA, $86.34, up $1.94) will be in the headlines a lot this week and there may be an opportunity for a couple of trades. News surfaced late Friday that Switzerland based Roche is preparing a fresh offer for Genentech which it already owns a 56% stake in. The stock was up another $2.66 in after-hours trading to $89.

We have been here before with these two companies and we did rather well playing the news back in the summer. Genentech will report earnings this week and will be presenting at the annual J.P. Morgan health care conference which runs today through Thursday. About 300 companies will be present but Genentech could steal the show.

Here are a few excerpts from the blog back then.

From July 27, 2008:

“Genentech (DNA, $96.00, up $1.35) continued higher throughout the week as it awaits word from a “special committee” that is evaluating the $44 billion bid to buy the company. Swiss pharmaceutical giant Roche is on the other end of that bid and is also waiting for an answer to its $89 a share offer.”

From August 13, 2008:

“Genentech (DNA, $98.53, up $0.68) will not win an academy award for its efforts in “evaluating” take-over offers but give the company credit for at least trying. The “special committee” that has been evaluating the $44 billion bid from Roche said this morning that the deal “substantially undervalues” the company and has been rejected.

This was no surprise as Genentech went on to say it “would consider a proposal that recognizes the value of the company and reflects the significant benefits that would accrue to Roche as a result of full ownership.” The language Genentech is using is sounding like a friendly deal could happen but it’s clear the company is holding out for a $100+ offer.

The August 95 calls (DWNHS, $3.60, up $0.85) continue to do well from an entry price of $1.50 and I mentioned you could ride them through Friday. However, we had set a stop of $3.00 so we were taken out yesterday. The August options expire Friday so make sure if you are still in the trade to close it before the trading session ends.

The September 100 calls (DWNIT, $2.95, up $0.45) were profiled at $0.65 and we have set a stop of $2.00-$2.25. The options closed at $2.50 yesterday so let’s make the $2.25 stop a firm one. I want to allow some room for volatility but I really don’t want the stop to kick in on this one. Genentech continues to set new highs and we want to ride the wave as long as we can.” –

This was six months ago and not much has changed as far as Roche acquiring Genentech except its stock price. The shares went on a slow fade and we were eventually stopped out of the trades but not before some healthy returns.

Roche’s new bid, which is expected to be about $95 a share is not much of a premium and would be another slap in the face to Genentech’s board. Roche is playing dirty and there is talk of a hostile takeover. Roche is giddy about Genentech’s top three drugs: Avastin, Rituxan, and Herceptin and $120 a share is more like a fair offer. I doubt we see it but those three drugs took in sales of over $1.7 billion last quarter as overall revenue came in at $3.4 billion.

Genentech’s pipeline is a force to be reckoned with and Roche knows this. Genentech is expected to report earnings of $0.96 and year-end earnings should come in at $3.40 to $3.45 a share. Despite a solid quarter, Genentech actually missed estimates last time out. No worries. I say let’s ride the Genentech wave higher and here are a few options that will be active.

The January 90 calls (DWNAR, $0.95, up $0.40) traded 10,000 contracts on Friday and expire this Friday. This will be the riskiest of the call options I list so stay away from them. With so many major announcements expected, the February and March call options will provide the same luxury with a little less risk.

The February 95 calls (DWNBS, $0.95, down $0.20) look good up to $1.25 while the March 95 calls (DWNCS, $1.70, down $0.10) look good up to $2.00.

Rick Rouse
Rick@OptionsMentoring.com

Tags: Genentech, Roche
Posted in Company Commentary, Mergers and Acquisitions, Option Trades, Uncategorized | No Comments »

Genentech Ditto's ImClone, Rejects Offer

Wednesday, August 13th, 2008

Genentech (DNA, $98.53, up $0.68) will not win an academy award for its efforts in “evaluating” take-over offers but give the company credit for at least trying. The “special committee” that has been evaluating the $44 billion bid from Roche said this morning that the deal “substantially undervalues” the company and has been rejected.

Meanwhile, we closed half of the ImClone (IMCL, $64.00, down $0.51) August 45 calls (QCIHI, $19.50, down $0.15) at $19.00 on 8/1 and set a stop of $18.00 on the rest. These calls were profiled at $2.40 and our return is something even Michael Phelps would envy. These options also expire this Friday so we will go ahead and just close this one out today.

I believe both firms will get higher offers but as always it depends on timing. If Genentech continues higher from here, the September 100 calls should continue to do well. As for ImClone, I’m not sure if there is another good trade out there for us or not. I’ll take a look at the option chains and run some figures but for now we will just go with Genentech.

Rick Rouse
Rick@OptionsMentoring.com

Tags: Genentech, Imclone, Mergers and Acquisitions, Roche
Posted in Mergers and Acquisitions | No Comments »

Genentech Hits All-Time High

Tuesday, August 12th, 2008

Genentech (DNA, $98.12, up $0.29) has hit an all-time high this morning. Although we still haven’t heard from the company’s “special committee” that is evaluating the $44 billion bid from Roche, there’s a research note out this morning saying Genentech was worth $130 a share.

The analyst went on to say there was an 80% chance of Genentech getting a bid of $105 or higher while the other 20% says a deal falls through and the stock trades back to $86. That a pretty good way of breaking it down I suppose but I mentioned back in July the stock was worth $125.

On 7/22, I profiled the August 95 calls (DWNHS, $3.40, up $0.65) at $1.50 and the September 100 calls (DWNIT, $2.75, up $0.25) at $0.65. At the time I said the August calls were a little riskier because they only had three weeks until expiration but the stock could still trade higher. As I mentioned earlier, I didn’t think we would see another offer from Roche by the time the August 95 call options expire on Friday. They are now up well over 100% and stops should be set at $3.00 to ensure that 100% return. You can ride these calls until Friday but make sure you close them or they will get exercised because they are deep in-the-money.

The September 100 calls have literally been “money” for us. This trade is now up 250% and the calls are still out-of-the-money. In other words, if Genentech trades flat from here on out and doesn’t break $100 by September 19, the calls will be worth zero. The $2.75 is all expensive time premium and will slowly evaporate if Genentech stalls from here.

I don’t think that will happen but you never know. It would wise to set stops on the September calls at in the $2.00-$2.25 range. I’ve still got my fingers crossed for a higher bid although I don’t think one will come by Friday for the August 95 calls to benefit much more. The September 100 calls have the potential to explode if a bid of $105 comes. Then again, they already have exploded if you got them back in July. Stay tuned…

Rick Rouse
Rick@OptionsMentoring.com

Tags: August call options, Genentech, Roche
Posted in Company Commentary, Hot Stocks | No Comments »

Our updated 2012 Track Record is now at 85-18 for an 82% win rate. We have closed 24-straight winning option trades since late March!

Despite the recent volatility, we have given more "locks" to our subscribers than a Vegas bookie. If you started with a $10,000 trading account, our CLOSED option picks would have made you over 600% by now. In other words, YOUR $10,000 option trading account would be worth over $70,000 as we have become one of the most powerful option newsletters in the business. Our biggest trade of the year so far was hit in early May when shares of Green Mountain Coffee Roasters (GMCR) fell 50% after an earnings miss which made our subscribers 576% on the put options!

We DON"T count "half" closed trades twice, or "third" closed trades three times like other option newsletters do. Some option services will fluff their Track Records up by using these smoke-and-mirror tricks. They will also "average down" a losing trade in hopes of it coming back then will record the "average" price of the trade when it was really 2 bad trades. Most option websites DON'T have track records and say they give 300% winners. The devil is in the details.

We don't play these types of games which is why we have the most dedicated subscribers in the business because we have earned their trust. We have recommended 103 trades, 85 winners, 18 losers for 2012. Pretty simple and pretty powerful. We also have verified auto-trading partners who trade our recommendations for your account if you cannot watch the market. They will also tell you how good and how honest our service is.

Here are some of our other profitable triple-digit recommendations: Capital One (COF) call options +423% in 8 days, American Express (AXP) call options +310% in under 7 days, magicJack (CALL) call options +80% in 3 days, Microsoft (MSFT) call options +124%, STX call options +100% in 2 weeks, +114% and +131% on 2 MGM Resorts (MGM) call options trades in 3 weeks, +158% on Zynga (ZNGA) call options and +107% in Aflac (AFL) call options in 6 days. We also had a +200% winner with Scientific Games (SGMS). Some of our double-digit gains include +58% on WPRT calls, +80% on TSM and +38% on INT call options.

Our Weekly Wrap is 35-0 since the start of 2011 and is 17-0 for 2012. Some of our winners include +55% on Solazyme (SZYM), +27% on Clean Energy Fuels (CLNE), +38% on Vivus (VVUS), +17% on MGM, +18% on Dendreon (DNDN), and +20% on Darling (DAR). Despite what the suit-and-ties say, you can make incredible gains trading the RIGHT covered calls.

Over the past 5 years we are averaging a 75% winning percentage for all our trades despite volatile, flat and choppy markets. Come see why some of Wall Street's pros are following us instead of the Journal!

Here are some of our profitable 2011 recommendations: ORLY call options +191%, VMW call options +100%, JOYG call options +169%; GS put options +184%; FDX put options +164%; OXY put options +74%; +137% on RIMM put options, +1,167% on RMBS puts in 11 days, +296% on FCX calls; +157% on ZAGG calls; +110% on LNKD puts; +133% on RLD put options.

You can also request our Track Records to see all years by entering your email address which will allow you access to the portfolios.

If you are missing these juicy profits, come give us a try. Get your password to our Members Area instantly when you sign up TODAY! One profitable trade will easily pay for your membership. You can request our 2008-2011 Track Records by sending us an email or filling out the box below. 665 Total Trades; 459 WINNERS or 7-out-of-10.

I just want you to know that I love the way you write and explain everything. I am new to this, and have lost 50% of my account until I met you guys. Iit is slowly coming back. I will be calling to set up a year
of membership rather than the one quarter. Thanks again, and LOVE YOU ALL. REGINA L.

Rick, I appreciate the advice. I think I will just sit back and utilize your selections only for awhile. This will obviously save me a great deal of money in commissions. I have gone thru your entire site including the video on money management. This has brought me to the stark realization that I have been trading too much for too little. I definitely have not been "swinging for the fences", but I also think I have been getting impatient with trades and getting out too fast. This has no doubt caused me too trade too much. I like, and definitely agree on, the advice on money management. Thanks for the help. STEVE T.

Thank you!!! I held on to the NFLX position since Nov. 13 at a cost of $1.89. Sold ½ on April 14th for a 540% return and the other ½ upon earnings for 702% return. Total profit of $11,615 a 621% return. Keep the recommendations coming and thanks to you and your team for the service you provide. SCOTT H.

Rick & Team, GREAT Call on NKE for my two trading accounts:
1) Entry at .65, out at 1.45, 1.55 Profit = $415
2) Entry at .60, out at 1.75, 1.50 Profit = $485 PETER G.

Hey Rick! Here is an update on what your picks have done in my accounts.

1) Great call on the JoyG March 55. I bought when you said, then bought again on one of the dips. Booked 80+% profit. Made enough to pay for your service for years to come.

2) Also booked profits on your Berk Feb 74 (80%) and threw a major chunk of change at the March 75’s (190+%). I would have never known that Buffet's stock had split if it weren’t for your service. Bought the shares also for the long haul. Won’t look at them for another 20 years. Great job on getting us in before the indexes did.

3) Took profit on your Imax March 12.5. 20 cent trailing stop at 1.90 yesterday. Not sure what the profit on that was, but profit is profit.

I see that you took a loss on some of these. It’s all good. I look to trade your “ideas” not your exact calls. I THANK YOU! For your ideas and commentary. Keep up the good work. And keep those ideas coming. LAWRENCE O.

Loving this subscription so far! I got into the BRK feb 76 calls the day you talked about right before the split...now up over 300% (0.70 to 2.475)! Keep the good picks coming and let's see some OSIS and EMC upside soon! Just wanted to share my positive enthusiasm on your newsletter...it gives us individual investors great ideas on not only the options market, but also the broader equity market! Case in point is BRK...I can't always read the breaking business news but its easy to read your twice daily updates on my smartphone...helped me get some BRK shares immediately after the split which I will hold for the long haul! Thanks again! C.J.

Aloha Rick - Thank you so much for the great CL pick. I am not sure if there was buy-out/merger news or what but at 3PM today Colgate-Palmolive absolutely EXPLODED to the upside, and my calls turned into green candy when they went from 1.40 to 3.8 in a matter of seconds! I even sold a few for over 4.0! Much thanks and keep the solid picks up my friend, honestly. Only a fool would scoff at 267% gains... Peace! SHAUN

I like the fact that you ask for comments from subscribers. Good customer service. By the way, am enjoying the service so far. Some good profitable calls. Keep up the good work. MICHAEL K.

Woo hoo! Out for 50% on WMT this am. Making up for my depression for getting out of pcln for a 30% gain monday :( you the man! any word on the manual? My friend Mike ( who I sent to your service) told me he emailed you about your integrity in reporting fills. I echo that sentiment big time.. keep it up! Cheers!
PARAG P.

Hi Rick, as a new member all I can say is, 'show off' LOL, with PCLN. JAY P.

Rick, I am a new subscriber to your service, and I want to say I am impressed. I am impressed by your results, but more than that I am impressed by your reporting of your fills. You could have easily said you got that Wal-Mart call today for 80 cents, instead you reported 98 cents! Good job and keep it up, I watched the reporting of the fills first, and then I subscribed. Thank You. MIKE

Hi, good morning. I jumped the gun a little on this one (PCLN). But still made $1,675.00 profit!! Very happy!! Keep up the good work!! Thanks. TRISH D.

Hi there, I have joined recently, and I am very happy to tell you that I am up over $10,000 on your picks in a month. I started on 10/7 with the Intel pick. I'll be your member for life. Please don't quit on us. Also, I am learning a lot about options. I didn’t get in your recent APOL and that gold trade and only had one loss on CHK. I appreciate all the DD you do. I enjoy your market commentaries. Best advice site period, and I have tried a few here and there. Again, you guys rock! MIN L.

Thanks be to Momentum Options Trading for providing me with some fantastic wins. I just started with this service and am up nearly 50% in less than a month. There have been losses, but if I manage them properly, I will continue the best efforts given on the blog (in which there are no complaints). What a great cause for humanity. I feel more confident about my trades and continue to play the wins. Best of all, I am now keeping my regular paychecks in the bank! Thank you! JOE G.

Rick - I wanted to say thanks for getting me started on the right foot with your service. I have made six trades since starting on October 22, 2009. Five are winners and One loser netting me $6,245. Thanks again and keep the trade recommendations coming. GREG F.

I got into the Nike 60 Call at 1.85, sold at 5.00, also bought a 55 put at 1.05, but got stopped out at .35. What a ride! $2830.00 in the black even with the put. It's right at 100% return. I hope earnings season coming up is going to look like this trade. NOEL

Nice call on Nike. I think I'll go buy a pair with my profits! : ) I did the straddle for safety but still made 62% on the trade. Not bad for less than 24 hours. If Goldman is right, then the Nov 70s or 75's could be a steal today. TODD F.

What a sweet way to get introduced to Momentum. My first trade based on your picks and it a 2X. Thank you! PAUL H.

“Limit order was set at 1.60 on RIMM so it sold. I may have left some money on the table but you can't go broke making a profit. That was a fun trade. Thank you. Good call. I’ve been watching and trading Rick's advice since March. It’s usually a fun ride, but I give him heck when it's wrong to. :) ” NOEL

“Your service rocks! I made bank on Dendreon last week! The other thing I have to say is that it took me quite a while to find a REAL options trading service like yours. Most of what’s out there is 99% scam and very sketchy. Momentum Options Trading is the first service I found that I can trust and seriously make money with.” CHRISTIAN

“I made $420.00 on ANF in 2 days. Thanks for the trade and updates on getting out of the trade.” JOHN

“I did follow a lot of your trades with 1-2 contracts per trade and YTD I’m up 108%. I try not to follow blindly by not entering all of your trades and sometimes entering the ones you don’t. I entered AIG a few weeks ago against recommendation – that one hurt.” CHARLES M.

“I have been following you for several months and am interested in the new service. I hate to see the free service go away but as they say, “all good things must come to an end”. My ability to join will be greatly influenced by the monthly fee so I’m very curious to see the new prices. Thanks for making April a great month for me and my family.” BRYAN C.

“I have really enjoyed the past month since finding your blog. You have made some great calls. I would appreciate info. on the new options mentoring program. Thanks.” JOHN H.

“Hi Rick, I have been following your blog for several months now and I would like to be including on the list for your new service and to receive more information about it. And yes I was a Dendreon winner with your tips. Turned $280 into $7700, and literally saved my butt.” JEFFREY

“I made over 6k on your Dendreon trade, and I’m very interested in learning how you pick and trade options. Sign me up.” ED

“Rick – Wow what a day! I got in at the Dendreon calls at $2.25. Thanks to for your advice. I appreciate that. This company has a lock on this type of therapy and no one else in the world is close. Kind of reminds me of the type of companies that Peter Lynch and Warren Buffet suggest that investments be made in. Companies that can build a moat around their business model, that allows them to charge a premium for their product or service. In other words - a monopoly.” GREG

“Hi Rick, Thank you so much for the Dendreon trade, I made almost $10,000 with that trade with a little over $2,000 investment. You have shown me the power of options trading. Again, thank you so much for all your inputs.” KEN

“Hi Rick, thanks for the encouragement to play the dendreon calls! did freaking great! Got in the first lot at $1.44 on 3-24-09, sold at $2.45, 70% not bad. Bought it back at $2.30 on 4-7-09 closed out on 4-14-09 for 454% gain! Wow! I love it when that happens. So, thanks the encouragement to get back in when others were saying sell, sell, sell. Keep up the good work.” GARETT

“Rick – Thanks for Dendreon – it has made all the headlines today! I missed on RIMM earlier, but I’ve been holding onto DNDN calls since 3rd week March. Of course today it all paid off today, as DNDN rocketed up.” TERENCE

Jan. 31 2012
Rick, new member...Studied all current trades, did some chart work,picked ZNGA, PEP, MGM...Sold on Feb. 2 for $3600.00 profit...Cost for 1-year membership to your newsletter was less than $1000.00..All I have to say..Thank you. John H –

3/18/11
Rick, I purchased 10 contracts of the Nike March 85 puts Thursday afternoon for $2.00. Thing is, I was upset because the puts went down to $1.60 or so before the market closed. Well, needless to say Nike didn’t impress Wall Street and when I turned on the computer this morning the puts were worth $7.10! Sold them for a $5,100 profit!. Thanks again, you are the MAN. Chuck J-

2/3/12
Hi Rick,

I will start off with a thank you for your time and dedication to all
the research you and your team commit yourself to. This is not me just being excited about the profits I have accumulated aka (bank) ! You have helped me get back to the passion I had of researching stocks/options. Keith N-

Hi Rick,

I want to share my great results on GMCR. Based on your comments on February 15th, I bought 20 options at $0.28. They closed today at $7.00, which is a 2,300% gain. My $560 dollars turned into $14,000 in less than a month. In decades of trading, this is my single best trade ever. Thank you! By the way, the Dow was down 228 points today and I could care less. What a great trade. It proves the amazing power of options. I am so grateful for your service, which calls it straight all the time, your options trading manual, and most of all, your amazing skill
at finding winning trades. I have attached a copy of the trade from
my brokerage screen.

Hi Rick,

Wow!! my account it up 70% since i joined last month and market is going the opposite direction. Really appreciate your service. I just wanted to drop a note to say THANK YOU. Hope to be with you guys for a very long time. Mel

Rick,

Great call on Fosl I bought the may 120 puts for 3.70 yesterday morning just sold for $32.00 today
Keep up the great work
Thank you, Henri

Rick –

I bought 10 Deckers Outdoor (DECK) May 55 puts at $0.50 on 4/26/12 and sold them on 4/27/12 for $1.65. I made $1150 in one day. Thanks. I knew something good would happen sooner or later.
HOW THE HECK did you know Green Mountain Coffee (GMCR) was going to go down 20 points???!!!! I bought 10 of the May 35 puts at $0.49 and then 5 more at .30. I sold them at 5.80. Thank you again.
You have made a believer out of me. Alan

Rick –
I have only been a member for about 6 weeks but I have done well on most of the trades. My first two were QQQ and SPY a month ago and since then I've gotten into the groove and been doing well.
I try to execute the trades that you recommend as soon as you send them out, sometimes I can't and I miss the Entry price. However, sometimes when I miss the Entry, the price goes down and I get a better price.
That's exactly what happened with GMCR.
You recommended it at around $.81 I think, but by the time I got to it, the price was $.27. I bought 100 Puts on Wednesday May 2, 2012 and sold half of them 24 hours later at $5.95 for a nice 2,203% gain. As per your recommendation, as GMCR went above $30 I sold the remaining 50 Puts at $5.50 for a slightly less 2,037% gain.
On average that one trade netted me a 2,120% gain, entirely based on YOUR recommendation (and a little bit of luck). To put this in real terms, I risked $2,700 on Wednesday and pocketed $54,550 just 24 hours later.
So uhh, let's do that again real soon!!
Feel free to use my name. The tax guys have me on speed-dial already anyway. Dennis

Rick:
That was awesome on your GMCR pick, I know how risky it can been holding into earnings but you pulled it off.
I just started my autotrading with you today and am in on your QQQ play. I look forward this service.
I have a busy career and I have tried to follow and trade throughout the day and found it too hard. I hope you continue to have a great year, I plan to go along for the ride. I am starting slow but will pile more in once I have secured some profits.
Keep up the good work your trading has been spot on. I am sure you paid your dues to get this point in your career. Anthony

Rick:

Great call on GMCR! I have been trading for about 15 years actively. This may be the best trade I ever made. Got in on Monday, April 30 and the stock was up from when you recommended it. It went up further after I got in. Here are the facts:
Monday, April 30th: Bought 15 June 37's at $1.25= $1900 approx
Thursday, May 3rd: Sold 15 June 37's at $9.30=$13,950
Gain for the week: $12,050.
I understand you will not get them all right. It’s important to ride those winners and as you could tell from my selling price, I sold when the stock went to $28.10, so left a little on the table. Who can complain.
Keep the suggestions coming, looking for another jump on your FSLR, one that I have been riding very hard.
Best regards, Bob

Posts Tagged ‘Roche’

Dendreon Making Noise Again

Roche Goes Hostile

Before the Bell – Action in Genentech

Genentech Ditto's ImClone, Rejects Offer

Genentech Hits All-Time High